patient's hormone receptor status. 19 Pregnancy testing before, during, and after cancer treatment should be discussed. A shared decision-making approach to pregnancy testing and cancer treatment is an effective way to involve patients while maintaining
Search Results
Annika M. Gustafson, Deborah J. Goldfrank, William A. Dunson, Daniel L. Mulkerin, Rebecca L. Caires, and Keith D. Eaton
Michelle L. McDonald and J. Kellogg Parsons
Charting an even-handed, evidence-based path between the 2 extremes involves tailoring early detection efforts toward screening of younger populations and developing more stringent biopsy criteria. Informed and Shared Decision-Making Screening
Sharyn F. Worrall, Andrea J. Dwyer, Reese M. Garcia, Keavy E. McAbee, and Anjelica Q. Davis
for adverse effects, (3) reduce stress stemming from the patient–caregiver relationship, and (4) support patients and caregivers in shared decision-making by enabling risks and benefits to be discussed and patient values to be incorporated into
Robert J. Morgan Jr
usage of complementary and alternative medicine . J Cancer Res Clin Oncol 2013 ; 139 : 1515 – 1522 . 3. Thiel FC Schrauder MG Fasching PA . Shared decision-making in breast cancer: discrepancy between the treatment efficacy required by
other stakeholders involved in the treatment decision-making process, as a means to initiate a discussion of value between a provider and patient. Together, the 5 measures encourage shared decision-making based on a patient's individual values. NCCN
Patricia A. Ganz
when they are trying to complete diagnostic tests and make decisions about a treatment plan. The IOM report details many of the challenges inherent in effective patient-centered communication and shared decision-making, focusing Figure 1 A model
Robert W. Carlson and Eric Jonasch
in shared decision-making.” He said the NCCN Evidence Blocks are not prescriptive, but they are a starting point for a productive conversation between patient and physician. Available for 10 Tumor Sites Each evidence block is compiled from
Presenter: Amye J. Tevaarwerk
, but shared-decision making could mitigate the impact,” she said. “In the metastatic setting, however, recognition of patient priorities considering treatment and contextual characteristics, such as efficacy, toxicities, impact on daily life, and
on the following areas where gaps in care currently exist: Provider education and provider/patient treatment shared decision-making Adoption of evidence-based recommendations for management of metastatic breast cancer Information related to
of hematologic malignancies and explored treatment advances in T-cell lymphomas, diffuse large B-cell lymphoma, multiple myeloma, and acute lymphoblastic leukemia. Experts also discussed best practices for supportive care and shared decision-making. A